NZ605317B - A Formulation for Topical Administration And A Method Of Its Use - Google Patents
A Formulation for Topical Administration And A Method Of Its Use Download PDFInfo
- Publication number
- NZ605317B NZ605317B NZ605317A NZ60531712A NZ605317B NZ 605317 B NZ605317 B NZ 605317B NZ 605317 A NZ605317 A NZ 605317A NZ 60531712 A NZ60531712 A NZ 60531712A NZ 605317 B NZ605317 B NZ 605317B
- Authority
- NZ
- New Zealand
- Prior art keywords
- formulation
- skin
- teats
- present
- teat
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 89
- 238000009472 formulation Methods 0.000 title claims description 78
- 230000000699 topical Effects 0.000 title description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000011780 sodium chloride Substances 0.000 claims abstract description 39
- 235000011187 glycerol Nutrition 0.000 claims abstract description 34
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 30
- 239000003085 diluting agent Substances 0.000 claims abstract description 21
- 239000003974 emollient agent Substances 0.000 claims abstract description 20
- 230000000845 anti-microbial Effects 0.000 claims abstract description 18
- 239000012049 topical pharmaceutical composition Substances 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 10
- KHLVKKOJDHCJMG-QDBORUFSSA-L disodium;(2E)-3-oxo-2-(3-oxo-5-sulfonato-1H-indol-2-ylidene)-1H-indole-5-sulfonate Chemical group [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 claims description 7
- 229960003988 indigo carmine Drugs 0.000 claims description 7
- 235000012738 indigotine Nutrition 0.000 claims description 7
- 239000004179 indigotine Substances 0.000 claims description 7
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 6
- 235000011399 aloe vera Nutrition 0.000 claims description 6
- 240000005513 Aloe vera Species 0.000 claims 1
- 210000002445 Nipples Anatomy 0.000 abstract description 71
- 235000013365 dairy product Nutrition 0.000 abstract description 19
- 208000004396 Mastitis Diseases 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 7
- 210000004080 Milk Anatomy 0.000 abstract description 6
- 201000009910 diseases by infectious agent Diseases 0.000 abstract description 6
- 235000013336 milk Nutrition 0.000 abstract description 6
- 239000008267 milk Substances 0.000 abstract description 6
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000014104 aloe vera supplement Nutrition 0.000 abstract 1
- 210000003491 Skin Anatomy 0.000 description 42
- 239000007921 spray Substances 0.000 description 38
- 239000000975 dye Substances 0.000 description 27
- 150000003839 salts Chemical class 0.000 description 24
- 239000000470 constituent Substances 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 14
- 238000010790 dilution Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 9
- 241000124008 Mammalia Species 0.000 description 9
- 230000002829 reduced Effects 0.000 description 9
- 239000012224 working solution Substances 0.000 description 9
- 230000000670 limiting Effects 0.000 description 7
- 238000005336 cracking Methods 0.000 description 6
- 244000144980 herd Species 0.000 description 6
- 230000001717 pathogenic Effects 0.000 description 6
- 244000052769 pathogens Species 0.000 description 6
- 244000144927 Aloe barbadensis Species 0.000 description 5
- 206010022114 Injury Diseases 0.000 description 5
- 230000003385 bacteriostatic Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010060945 Bacterial infection Diseases 0.000 description 3
- 210000000481 Breast Anatomy 0.000 description 3
- 229960003260 Chlorhexidine Drugs 0.000 description 3
- 229940011411 Erythrosine Drugs 0.000 description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 3
- 235000012732 erythrosine Nutrition 0.000 description 3
- 239000004174 erythrosine Substances 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N Rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000844 anti-bacterial Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 206010000496 Acne Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 240000004559 Cuminum cyminum Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010049796 Excoriation Diseases 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 210000003780 Hair Follicle Anatomy 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010061255 Ischaemia Diseases 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 210000001732 Sebaceous Glands Anatomy 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000003977 dairy farming Methods 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000004681 psoriasis Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Abstract
No. 605317 Disclosed herein is a topical formulation comprising - by weight – a diluent (preferably deionised water), 25-60% of an emollient that is glycerol (glycerine, glycerine), 5-20% sodium chloride as an antimicrobial active ingredient and additionally aloe vera extract. Further disclosed is the formulations use as a teat dip for treating damage or infection to the teats of dairy cows or other milk producing animals, including mastitis. is the formulations use as a teat dip for treating damage or infection to the teats of dairy cows or other milk producing animals, including mastitis.
Description
James & Wells ref: 133330/47
A FORMULATION FOR TOPICAL ADMINISTRATION AND A METHOD OF ITS USE
TECHNICAL FIELD
The present invention relates to a formulation for topical administration. The invention
has particular application to the preparation and use of a topical formulation to be
applied as a spray to the skin for treatment or maintenance.
BACKGROUND ART
Dairying is a significant primary industry in New Zealand, and significant investment is
made in ensuring the health and wellbeing of dairy cows. The health of a cow can affect
its productivity.
One common issue that arises in the management of dairy cows is the condition of the
skin of the teats of the dairy cow. The skin acts as a barrier to moisture and pathogens.
The skin barrier protects the internal environment of the body from excessive absorption
of water and other solutes that may be found in the environment.
The skin of the teats of dairy cows can become damaged as a result of machine milking.
The use of pulsating teat cups in machine milking can result in some minor skin trauma
such as abrasions, grazes and blisters. Such trauma, if left untreated, can result in
ischaemia and ulceration of the skin.
Furthermore, in the field, the teats are often exposed to moisture and other pathogens.
This is particularly the case during the wet spring months of the milking season.
Prolonged exposure to moisture and detritus on the teats can result in the loss of natural
secretions, such as glycerol, which are expressed from the sebaceous glands of hair
follicles onto the skin. Glycerol assists in the hydration of the skin which is important to
its function as a barrier.
The loss of such secretions can disrupt the function of the moisture barrier of the skin,
leading to an increased susceptibility to infection.
James & Wells ref: 133330/47
To help care for the teats of dairy cows, some dairy farmers will wash and clean the
teats on a regular basis. However, excess washing and cleaning particularly with
detergents and soaps, can strip the skin of the udder and teats of its natural emollients.
This subsequently can lead to cracking and scarring of the skin surface, which in turn
can potentially lead to bacterial infection.
The cracking of the skin of the teats can also have detrimental effects on milk
production. The milking action on teats having cracked skin can lead to pain-avoidance
behaviours, such as retaining milk.
As an alternative to the use of detergents and soaps, teats sprays may be used by dairy
farmers to help maintain healthy skin on the teats of dairy cows. The spray can also
assist in the repair of minor injuries to the teats as well as help prevent and/or control of
mastitis and other bacterial infections that may develop in the teats and udders of dairy
cows.
Conventional teat sprays generally use inorganic chemicals as their active antimicrobial
agent. Such chemicals include iodine or chlorhexidine. An example of one such teat
spray is TeatX , manufactured and distributed by Deosan (www.deosan.co.nz).
Iodine and chlorhexidine are relatively expensive actives, and therefore the manufacture
of teat sprays can represent a significant financial investment. There is also a
subsequent impact on the retail price per unit for such teat sprays. Conventional teat
sprays are often provided as concentrates which have to be diluted for safe use. Using
iodine at too high a level can result in burns. Furthermore, because of the expense
involved, care must be taken when diluting the concentrate. However, it should not be
diluted too much as the teat spray may have reduced efficacy.
The use of chemicals as actives can also create toxicity and environmental issues.
Many active agents used in teat sprays are not generally recognised as safe (GRAS).
Furthermore, conventional teat sprays can represent a food safety or residue threat to
James & Wells ref: 133330/47
people consuming milk or dairy products derived from cows treated with conventional
teat sprays.
There is an increasing awareness amongst the public for the need for environmentally
friendly conduct by industries and businesses. Dairy farming is no exception, and there
is a growing shift way from the use of potentially harmful chemicals, such as those used
in many veterinary products, which may enter the food chain in a variety of ways.
Thus, in New Zealand there are increasing numbers of dairy farms that are being
managed in such a way to obtain organic certification by recognised bodies such as
AsureQuality (http://www.organiccertification.co.nz/). To achieve this certification the
use of non-organic chemicals, such as teat sprays including iodine or chlorhexidine, is
not desirable. All constituents of a formulation must be approved before organic
certification of a particular product can be allowed.
However, this then limits the organic dairy farmer in their choice of available products for
management of the teat condition of their cows. Such products are preferably animal-
friendly while also being as environmentally sensitive as practical.
It is an object of the present invention to address the foregoing problems or at least to
provide the public with a useful choice.
Further aspects and advantages of the present invention will become apparent from the
ensuing description which is given by way of example only.
All references, including any patents or patent applications cited in this specification are
hereby incorporated by reference. No admission is made that any reference constitutes
prior art. The discussion of the references states what their authors assert, and the
applicants reserve the right to challenge the accuracy and pertinency of the cited
documents. It will be clearly understood that, although a number of prior art publications
are referred to herein, this reference does not constitute an admission that any of these
documents form part of the common general knowledge in the art, in New Zealand or in
any other country.
James & Wells ref: 133330/47
Throughout this specification, the word "comprise", or variations thereof such as
"comprises" or "comprising", will be understood to imply the inclusion of a stated
element, integer or step, or group of elements integers or steps, but not the exclusion of
any other element, integer or step, or group of elements, integers or steps.
DISCLOSURE OF THE INVENTION
According to one aspect of the present invention there is provided a topical formulation,
wherein the formulation includes:
a diluent, and
an emollient, and
an organic antimicrobial active
characterised in that
the organic antimicrobial active is sodium chloride.
According to another aspect of the present invention there is provided a preparation for
a topical formulation, wherein the formulation includes:
a diluent, and
an emollient, and
an antimicrobial organic active
characterised in that
the organic antimicrobial active is sodium chloride, and wherein the formulation also
includes a herbal extract.
According to another aspect of the present invention, there is provided a method of
treating a condition of the skin of a mammal with a topical formulation, wherein the
James & Wells ref: 133330/47
formulation includes a diluent, emollient, and an organic antimicrobial active, wherein the
organic antimicrobial active is sodium chloride,
the method characterised by the step of:
a) applying the formulation to the skin of a mammal.
According to another aspect of the present invention, there is provided a method of
treating a condition of the skin of a mammal with a topical formulation substantially as
described above, the method including the additional step prior to applying the
formulation to the skin of the mammal of:
b) diluting the formulation with water by a factor of between approximately 3:1 (2
parts water to 1 part formulation) and 10:1.
The present invention relates to a topical formulation intended for application to the skin
of a mammal.
The mammal may be any mammal that may require treatment of the skin. For example,
the mammal may be a human, dog, a cow or the like. Reference shall now be made
throughout the remainder of the specification to the mammal being a cow, although this
is not meant to be limiting. Cows are valued as dairy animals, and dairying is a
significant primary industry in many countries. However, it will be appreciated that goats
and sheep are also valued dairy animals, and the present invention may readily be used
with these animals as well.
The formulation may be applied to any area of the skin which may have a condition
requiring treatment.
The condition may be any condition in which the skin becomes damaged or dehydrated.
For example, the condition may be cracking, chafing, windburn or sunburn of the skin.
Other examples of conditions to be treated with the present invention may be conditions
in which pathogens such as bacteria, fungi or viruses play a role, either causing skin
James & Wells ref: 133330/47
damage or dehydration of the skin or causing more serious conditions of damaged or
dehydrated areas of the skin, such as infection. Examples of such conditions include
acne, athlete’s foot, psoriasis or dermatitis. The stated examples of skin conditions are
not meant to be limiting and persons skilled in the art will readily appreciate a variety of
skin conditions may be treated with the present invention.
The formulation is to be applied to the area of skin requiring treatment or preventative
maintenance. For example, the formulation may be applied to the ears, nose or in skin
folds.
In preferred embodiments of the present invention, the formulation is applied to the teats
of cow, and reference shall now be made to the use of the present invention on the teats
of a cow.
The teats of a cow can become damaged as a result of machine milking or through
contact with the ground or objects in the path of the teats as the cow moves. Another
source of trauma to the teats can be excessive moisture, which can lead to the skin of
the teats becoming cracked. Such cracks then become points of entry for pathogens.
The present invention is ideal for use to treat or prevent damage to the skin of the teat.
The formulation may be applied to the skin in a number of ways, for example as a paste
or ointment. In preferred embodiments of the present invention, the formulation is
applied to the teats as a spray. Reference shall now be made throughout the remainder
of the specification to the formulation being used as a teat spray. An important aspect of
the present invention is that the constituents of the formulation are organic and
Generally Recognised As Safe (GRAS).
The use of organic in the context of the present invention should be understood to mean
that the formulation of the present invention does not include synthetic compounds.
GRAS is an acronym used by the United States Food and Drug Administration (FDA) to
refer to any substance that is approved by the FDA for intentional addition to food as a
James & Wells ref: 133330/47
food additive, unless the substance is generally recognised, by qualified experts, as
having already been sufficiently proven to be safe for its intended use.
The formulation may be provided as a concentrate which needs to be diluted with water
before application. Such an approach may be preferred by bulk users such as larger
scale dairy farms. Alternatively, the formulation may be provided to the consumer as a
working solution, ready for immediate use with no dilution step. Small scale users, such
as lifestylers, may prefer such products for being easy to use.
The constituents of the formulation are now discussed, and unless otherwise indicated
are expressed as a percentage of a concentrate which would need to be diluted by a
factor of approximately 5 parts to 10 parts water to 1 part concentrate.
The formulation includes a diluent or thinner.
A diluent should be understood to mean a diluting agent, and reduces the viscosity of
the remaining constituents of the formulation.
The diluent may be any suitable substance which is chemically inert, and persons skilled
in the art will readily recognise which liquids or substances would be suitable for use as
a diluent, depending on whether the formulation is to be applied to the cow as a paste or
spray.
For example, when the formulation is being applied to the animal as a spray, the diluent
may be water (formula H O).
In preferred embodiments of the present invention, the diluent is deionised water.
Deionised water is water from which any mineral ions have been removed. This
ensures the water is as pure as possible.
The amount of deionised water present in the formulation will depend on the amount of
emollient and microbial organic active that is also present, but in preferred embodiments
of the present invention, the formulation contains from 30 to 60% by weight of deionised
water.
James & Wells ref: 133330/47
In preferred embodiments of the present invention, the formulation contains from 30 to
40% by weight of deionised water, this being the appropriate amount of diluent required
for full dissolution of the organic antimicrobial active.
The formulation includes an emollient. An emollient should be understood to be a
moisturiser which acts to reduce evaporation of water in the skin, thereby increasing the
skin’s hydration.
In preferred embodiments of the present invention, the emollient has bacteriostatic or
antimicrobial properties.
In preferred embodiments of the present invention, the emollient is glycerin (also known
as glycerine or glycerol). This is not meant to be limiting and persons skilled in the art
will appreciate that other emollients may be suitable for use with the present invention.
Reference shall now be made throughout the remainder of this specification to the
emollient being glycerin.
The inventors prefer the use of glycerin in the present formulation for a number of
reasons. Firstly, the use of glycerin (formula C H O ) as an emollient is well known and
3 8 3
it plays an important part in the maintenance of a healthy skin barrier.
Glycerin is also known for its bacteriostatic properties. Bacteriostatic should be
understood to mean an agent that stops or inhibits bacteria from reproducing as
opposed to killing them, as is the case with a bactericide.
Glycerin may be cheaply and easily sourced, making it an ideal and cost efficient
emollient for the purpose of the present invention.
Furthermore, as it is GRAS, glycerin is commonly used in foods. This will facilitate
organic certification of the present invention.
A factor that affects the amount of glycerin that may be present in the formulation is its
limited ability to dilute the organic active. There must be a certain amount of diluent
James & Wells ref: 133330/47
present in the formulation as well in order to achieve the full dissolution of the organic
antimicrobial active.
In preferred embodiments of the present invention, the formulation contains from 25 to
60% by weight of glycerin. In a particularly preferred embodiment, the formulation
contains from 45% to 55% by weight of glycerin.
In an even more preferred embodiment, the formulation contains from 48% to 52% by
weight of glycerin.
The formulation also includes an antimicrobial organic agent. This should be understood
to mean that the organic agent has properties that inhibit, kill or otherwise detrimentally
affects bacteria, fungi, viruses and/or other pathogens.
In the present invention, the antimicrobial organic agent is sodium chloride.
Sodium chloride (formula NaCl), which throughout the remainder of this specification
shall be referred to as salt, although in some embodiments of the present invention,
iodised salt may be used, is known to have antibacterial properties. It is a natural
desiccant which may disrupt the metabolic processes of many pathogens.
The salt constituent of the formulation is its key active, and is particularly advantageous
for a number of reasons. These include:
readily available;
low cost;
readily soluble in water;
is approved in some countries for inclusion in organic formulations;
does not react with other ingredients.
James & Wells ref: 133330/47
The antimicrobial property of salt also supplements the bacteriostatic action of the
glycerin component of the formulation. The inventors have found when used as a teat
spray, the combination of salt and glycerin works surprisingly well in improving the teat
condition of cows treated with the teat spray. The glycerin acts to counter the desiccant
property of salt, ensuring the skin remains as hydrated as possible.
Additionally, the combined bacteriostatic nature of glycerin and the antimicrobial effect
of salt increases the efficacy of the formulation.
Furthermore, as it is GRAS, salt is commonly used as a food preservative. This will
facilitate organic certification of the present invention.
Salt is also hypertonic, and may act to reduce swelling and oedema in damaged teats or
teats affected by swelling associated with mastitis infections by drawing water away
from the swollen or damaged area.
However, salt is also a desiccant.
Thus the amount of salt present in the formulation needs to be an appropriate amount to
avoid excessive dehydration for which the emollient present is insufficient, while still
allowing a small degree of water loss to assist in reducing swelling associated with
trauma and infections.
In preferred embodiments of the present invention, the formulation contains salt in a
therapeutically effective amount by weight.
In preferred embodiments of the present invention, the formation includes from 5 to 20%
by weight of sodium chloride.
In a particularly preferred embodiment, the formulation contains from 12 to 13% by
weight of sodium chloride.
James & Wells ref: 133330/47
In preferred embodiments the formulation also includes a herbal extract which when
used on skin has therapeutic properties. In preferred embodiments of the present
invention, the herbal extract is aloe vera, although this is not meant to be limiting.
Persons skilled in the art will appreciate that other organic herbal extracts may also be
used according to the preference of the user.
For example, other organically certified extracts which are known to have beneficial
properties may be used as a constituent in the present invention. Such examples of
such extracts may be garlic, cumin and turmeric.
Aloe vera is well known for its soothing and restorative properties when used on the
skin.
In preferred embodiments of the present invention, the formation includes from 1 to 5%
by weight of aloe vera powder.
In some embodiments of the present invention, the formulation may include additional
constituents.
For example, when used as a teat spray, the formulation may include a dye. This is
useful when applying the teat spray as may indicate to the user the extent of the
coverage of the teat spray when applying it to the skin of the udder and teats.
The dye may be any suitable dye which is GRAS.
The inventors prefer Indigo Carmine supra food grade dye (CAS Number 8600)
and/or Erythrosine supra food grade dye (CAS Number 164230). Both dyes have
been approved by the FDA and the Food Safety Agency of the United Kingdom (FSA).
These dyes result in the formulation having a visibly detectable reddish colouring.
However, the disclosed examples are not meant to be limiting and persons skilled in the
art will appreciate that dyes for any colour may be used with the present invention so
long as they are recognised as being GRAS.
James & Wells ref: 133330/47
In preferred embodiments of the present invention, the formation includes from 0.1 to
2% by weight of dye.
Other optional constituents may include additional emollients and/or actives, so long as
such constituents are organic.
In a particularly preferred embodiment, the formulation, in its concentrate form, includes
the constituents as expressed in table 1:
Ingredient name (common or chemical) CAS Number Quantity Function
(g/kg)
Deionised water 77325 372.3 Diluent
Glycerine BP 565 504 Emollient
Sodium Chloride Solar Salt (Grade 27) 76475 122.5 Organic
antimicrobial
active
Erythrosine supra Food grade dye 164230 0.1 Food grade
Indigo carmine supra food grade dye 8600 0.1 Food grade
Aloe Vera powder 200:1 1000847 3 Herbal extract
Table 1: Constituents of the concentrate (prior to dilution to a working solution) formulation
(as g/kg) with an indication of the function of each constituent.
An example of a method of preparing the formulation shall now be described.
To a main tank of 100 litres, 32.03 kilograms of deionised water is added. The tank is
then heated to 45 to 50° Celsius.
While being heated, sodium chloride, 12.25 kilograms is added to the main tank,
together with 0.3 kilograms of aloe vera powder (200:1). The contents of the main tank
is mixed with a Silverson mixer for 15 minutes until the solution is clear and the
powders are dissolved.
Once the solution is clear, 50.4 kilograms of Glycerine BP is added, and mixed into the
solution.
James & Wells ref: 133330/47
A separate formulation is prepared for the dye. To a 10 litre tank containing 5 kilograms
of deionised water, 0.01 kilograms of Erythosine Supra FG dye is added together with
0.01 kilograms of Indigo Carmine Supra FG dye. The mixture is mixed to ensure even
dispersion, and is then added to the main tank.
The resulting solution is mixed for a further 10 minutes, with deionised water (0.3
kilograms) being added to bring the formulation up to 100 litres.
The formulation may then diluted by a factor of approximately 3 to 10 into a diluent
(water) for a working solution.
The inventors prefer a dilution factor of approximately 5:1 (four parts water to one part
concentrate). This dilution factor is consistent with conventional teat sprays making it
easier for the present invention to gain market acceptance.
However, this is not meant to be limiting, and good results have been achieved with the
preferred concentrate formulation being diluted by a factor of approximately 7:1.
Higher dilution factors, such as 7:1 or even 10:1, may be used if the herd is milked twice
daily as this represents an opportunity for the present invention to be applied twice a
day.
This may justify the use of higher dilution factors, as the twice daily application may
offset the reduced efficacy of the higher dilution. This may also allow prolonged use of
the concentrate.
The present invention offers a number of advantages, including:
a teat spray which may be produced in a cost effective manner;
a teat spray in which all its constituents are GRAS;
a teat spray in which all its constituents are organic, such that the teat spray may
be organically certified;
James & Wells ref: 133330/47
a teat spray that has a efficacy comparable or superior to conventional teat
sprays;
at the very least, the present invention offers the public a useful choice.
BEST MODES FOR CARRYING OUT THE INVENTION
The following experimentation is given by way of example, and is not meant to be
limiting.
Objective
The objective of the inventors was to develop an organic teat spray suitable for use on
dairy cows. The various formulations were trialed on a farm in the Northland region of
New Zealand. The dairy herd was milked once daily, and thus there were approximately
24 hours between each milking event.
Climatically, the season during which the formulations were trialed was consistent with
the previous season, in which conventional teat sprays were used.
Experiment
Formulation 1
A first formulation (F1) was developed in which the working solution (dilution factor 7
parts water to 1 part concentrate (the list of constituents of F1 tabulated below in table
2) included salt at approximately 59.16 g/kg and glycerin at approximately 27.38 g/kg,
the balance of the formulation made up of a diluent in the form of distilled water.
Dyes were added to provide an indication of coverage, these being Country Mile Red
Marker dye (Rhodamine) and FIL Done That dye (Indigo Carmine) but only in trace
amounts.
James & Wells ref: 133330/47
Ingredient name (common or chemical) Quantity Function
(g/kg)
Deionised water 394 Diluent
Glycerine BP 191 Emollient
Sodium Chloride Solar Salt 414 Organic
antimicrobial
active
Erythrosine supra Food grade dye 0.004 Food grade
Indigo carmine supra food grade dye 0.004 Food grade
Table 2: Constituents of the concentrate (prior to dilution) of F1 (as g/kg) with an
indication of the function of each constituent.
Results
The working solution was applied to the teats using a conventional hand held spray gun,
following the removal of the teat cups after each milking event.
After several days of use, it was observed that F1 appeared to result in excessive drying
of the teat. It was speculated that there was insufficient glycerin in the formulation to
counter the hypertonicity of the salt.
Formulation 2
A second formulation (F2) was prepared in which the salt content in the working solution
was decreased to approximately 53.36 g/kg and glycerin increased to approximately
41.41 g/kg.
As with F1, the working solution had been diluted from the concentrate by a factor of
7:1.
The dyes used were also increased but only in marginal amounts. This was to improve
the visibility of the residual colour of the F2 on the teats following application as a spray.
James & Wells ref: 133330/47
Results
The trial with F2 (and the third formulation) took place during the wettest part of the
season, when ground condition is at its poorest. Historically, this is when cracking of the
skin of the teats is at its worst.
It was observed that after ten days of trial with F2 that the teat condition improved
somewhat. The skin of the teat felt softer to the touch, and cracking was reduced from
what would have otherwise been expected for the time of the season.
However, the visibility of F2 following application to the teats remained inconsistent.
Visibility is an important factor when using teat sprays as it is preferable to be as
efficient as possible with coverage of the spray.
Formulation 3
A third formulation (F3) was then trialed. The glycerin content was increased
substantially to 92.80 g/kg while the salt content remained unchanged at approximately
53.36 g/kg. In an attempt to provide a more visible spray, the amount of dye used was
increased, from 0.00008 g/kg in the second formulation, to 0.001 g/kg for each of the
two dyes used in the third formulation. As with the previous formulations, the working
solution had been diluted by a factor of 7:1.
Results
Superior results were observed using F3 than seen when using F2. Teat condition
improved considerably and the cracking was significantly reduced.
It was later found that the manufacturer specifications for the salt were incorrect, and
the specific density was double from what was expected. Thus, F3, as well as the
previous formulations trialed, had a salt concentration twice what was intended.
James & Wells ref: 133330/47
Formulation 4
As a result of the issue with the salt concentration issue identified following the trial of
formulation 3, the new formulation (F4) was revised such that the working solution
included salt at approximately 28.42 g/kg, with glycerin being increased to approximately
117.2 g/kg. The concentration of each of the two dyes was increased to 0.00145 g/kg,
with the balance being 854 g/kg being diluent in the form of distilled water.
Results
The teats of treated cows showed a noticeable improvement, which was believed to be
as a result of the increase in glycerin. It was particularly noticeable that cows that had
ongoing problems with cracked teats began to show improved condition.
At the same time, somatic cell count (SCC) was generally reduced when compared to
animals being treated with conventional teat sprays in previous seasons.
Furthermore, subclinical mastitis in the treated herd was reduced, as measured by SCC,
was reduced by about 20% compared to the previous season, as tabulated in Table 3
below.
Date Previous season Current season
2/8 317 254
12/8 284 225
21/8 217 176
1/9 210 190
11/9 244 173
21/9 261 206
1/10 237 188
James & Wells ref: 133330/47
11/10 223 187
21/10 305 No data
1/11 267 232
Table 3: SCC (x 1000) of across a three month period of the previous season compared
to the current season in which formulations 1 to 4 were tested.
The incidence rate of mastitis also dropped by approximately 60% from the previous
season.
As the farm on which the formulations were trialed milked once daily, it is likely that
superior results may been seen on farms being milked twice daily, assuming the dilution
factor remained consistent with what had been trialed. It is possible that the concentrate
could be diluted further on farms operating herds milked twice a day; the reduced
efficacy of a single application could be compensated for by being applied twice, after
each milking event.
Further variations of the formulation were trialed in the following season to ensure the
results observed the previous season were not due to other factors.
When aloe vera, a certified organic herbal extract, was added to the formulation in an
amount of approximately 0.696 g/kg, further improvement in the condition of the skin of
the teats was observed.
At the same time, the dye was changed. It was found that the Rhodamine based dye as
used to date was not GRAS. As a result, the dyes were replaced with food grade dyes,
these being Indigo Carmine and Erythosine. Both were included in concentrations of
approximately 0.023 g/kg.
Additionally, it was decided to lower the dilution factor from 7:1 to 5:1 to make the
dilution factor consistent with conventional sprays. It was thought that this may assist in
the product gaining market acceptance once it enters the market.
James & Wells ref: 133330/47
Conclusion
When salt is used in a therapeutically effective amount in conjunction with an
appropriate amount glycerin to counteract the hypertonic effect of salt, positive changes
in the skin of the teats of the treated animals was observed.
Furthermore incidences of bacterial infections, i.e. mastitis, were reduced with a
subsequent positive effect on milk production of the treated herd when compared to
herds treated with conventional products.
Aspects of the present invention have been described by way of example only and it
should be appreciated that modifications and additions may be made thereto without
departing from the scope thereof as defined in the appended claims.
James & Wells ref: 133330/47
Claims (8)
1. A topical formulation, wherein the formulation contains: a diluent, and an emollient in an amount from 25% to 60% by weight, and an organic antimicrobial active in an amount from 5% to 20% by weight, characterised in that the organic antimicrobial active is sodium chloride, and wherein the emollient is glycerin, the formulation also including a herbal extract, wherein the herbal extract is aloe vera in an amount from 1 to 5% by weight.
2. The topical formulation of claim 1 wherein the formulation contains from 10% to 15% by weight of sodium chloride.
3. The topical formulation of claim 2 wherein in the formulation contains from 12% to 13% by weight of sodium chloride.
4. The topical formulation of any one of claims 1 to 3 wherein the formulation contains from 45 to 55% by weight of glycerin.
5. The topical formulation of any one of claims 1 to 4 wherein the diluent is water.
6. The topical formulation of claim 5 wherein the diluent is deionised water.
7. The topical formulation of any one of claims 1 to 6 wherein the formulation includes a dye.
8. The topical formulation of claim 7 wherein the dye is indigo carmine supra food grade dye. James & Wells ref:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013101672A AU2013101672A4 (en) | 2012-12-24 | 2013-12-24 | A formulation for topical administration and a method of its use |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ605317A NZ605317A (en) | 2014-01-31 |
NZ605317B true NZ605317B (en) | 2014-05-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180153177A1 (en) | Botanical antimicrobial compositions | |
WO2009053934A2 (en) | Use of metal astringents for the treatment and prevention of hairy heel warts | |
US9918991B2 (en) | Topical antimicrobial compositions and methods of using same | |
CN102697803A (en) | Cow nipple disinfectant with film forming and nursing effect, and preparation method of same | |
US9474729B2 (en) | Topical antimicrobial compositions and methods of using same | |
CN109223736A (en) | Composition, the drug and preparation method thereof for preventing and treating animal foot rot | |
Krupelnytskyi | Hygiene products for udder health of lactating cows | |
US8932655B2 (en) | Antiseptic teat dip microemulsion | |
WO2015103387A1 (en) | Dairy farm teat dip compositions and methods | |
AU2013101672A4 (en) | A formulation for topical administration and a method of its use | |
CN103083393A (en) | Disinfect and sterile spray for preventing bouine mastitis and preparation method of spray | |
WO2019173213A1 (en) | Compositions for the treatment of infections in feet | |
EP2384623B1 (en) | Powder composition for the prevention and treatment of animal hoof diseases | |
NZ605317A (en) | A Formulation for Topical Administration And A Method Of Its Use | |
NZ605317B (en) | A Formulation for Topical Administration And A Method Of Its Use | |
RU2739112C1 (en) | Preparation for treating and preventing subclinical mastitis in cows | |
Polova et al. | Substantiation of the film-forming agent selection in the composition of spray with copper and silver citrate | |
RU2787381C1 (en) | Cream for milking | |
Santos et al. | In vitro efficacy of teat antiseptics against Staphylococcus aureus strains isolated from bovine mastitis | |
AU2006203630B2 (en) | Intramammary formulations | |
ES2300217B1 (en) | COMPOSITION FOR THE TREATMENT OF UBRES IN MAMMALS AFTER MILKING. | |
RU2583932C1 (en) | Agent for post-milking treatment of cows teats | |
US20130129637A1 (en) | Method for producing reservoir layer for hoof treatment and reservoir layer | |
US20080050456A1 (en) | Intramammary formulations | |
CZ37412U1 (en) | A disinfectant |